Franchise opportunities compared

    Amerisourcebergen Drug vs Snooze Mattress Company

    Reviewed figures from each brand's Franchise Disclosure Document (FDD), side by side. Each figure carries its FDD year and page. This is not a ranking or recommendation, and the two FDDs may cover different years and location groups.

    Initial investment · Item 7

    Amerisourcebergen Drug

    $5,000 – $12,000

    2026 FDD · Item 7 · PDF p. 29

    Snooze Mattress Company

    $302,200 – $859,600

    2025 FDD · Item 7

    Initial franchise fee · Item 5

    Amerisourcebergen Drug

    Not available

    Snooze Mattress Company

    $49,900

    2025 FDD · Item 5 · PDF p. 1

    Royalty · Item 6

    Amerisourcebergen Drug

    Not available

    Snooze Mattress Company

    5%

    2025 FDD · Item 6 · PDF p. 11

    Before you compare

    • Amerisourcebergen Drug figures come from its 2026 FDD and Snooze Mattress Company figures from its 2025 FDD, so the years differ.
    • Snooze Mattress Company discloses more than one business format, so the investment range spans formats; the full report breaks them out.
    • Only Snooze Mattress Company has reviewed Item 19 figures here.

    Financial commitment

    Estimated initial investment (Item 7)

    Amerisourcebergen Drug

    $5,000 – $12,000
    xisting pharmacy with no GNP Private Label product on your shelves we estimate an investment of — 5000
    2026 FDD · Item 7 · PDF p. 29

    Snooze Mattress Company

    $302,200 – $859,600
    2025 FDD · Item 7
    Standard initial franchise fee (Item 5)

    Amerisourcebergen Drug

    Not available
    No single standard fee identified

    Snooze Mattress Company

    $49,900
    2025 FDD · Item 5 · PDF p. 1
    Royalty (Item 6)

    Amerisourcebergen Drug

    Not available
    No reviewed royalty record

    Snooze Mattress Company

    5%
    Royalty fee
    2025 FDD · Item 6 · PDF p. 11
    Brand / advertising fund (Item 6)

    Amerisourcebergen Drug

    Not available
    No reviewed brand or advertising fund fee

    Snooze Mattress Company

    2%
    System brand fee — 2%
    2025 FDD · Item 6 · PDF p. 11

    System scale & health

    Total outlets (Item 20)

    Amerisourcebergen Drug

    2,361
    Outlets at end of 2025
    2026 FDD · Item 20 · PDF p. 55

    Snooze Mattress Company

    Not available
    No reviewed outlet counts
    Net outlet change (Item 20)

    Amerisourcebergen Drug

    +2,162
    Calculated: 199 at end of 2023 → 2,361 at end of 2025

    Snooze Mattress Company

    Not available
    Only one year reported
    Outlet exits (Item 20)

    Amerisourcebergen Drug

    Not available
    No complete exit records for a year

    Snooze Mattress Company

    Not available
    No complete exit records for a year
    Franchising since (Item 1)

    Amerisourcebergen Drug

    Not available
    Not in reviewed records

    Snooze Mattress Company

    Not available
    Not in reviewed records
    Franchisor founded (Item 1)

    Amerisourcebergen Drug

    Not available
    Not in reviewed records

    Snooze Mattress Company

    Not available
    Not in reviewed records

    Financial performance (Item 19), by location group

    Amerisourcebergen Drug

    No reviewed Item 19 figures

    Snooze Mattress Company
    Locations counted not stated in the reviewed record
    $100,643
    other Gross revenues
    2025 FDD · Item 19 · PDF p. 66

    Item 19 groups are shown separately and never combined. Revenue or sales figures are not profit. Net outlet change and turnover are Franopolis calculations from the disclosed counts; turnover is a count-based rate, not a measure of owner earnings.

    Amerisourcebergen Drug vs Snooze Mattress Company: common questions

    Which costs less to open, Amerisourcebergen Drug or Snooze Mattress Company?
    Amerisourcebergen Drug: $5,000 – $12,000 (2026 FDD · Item 7 · PDF p. 29); Snooze Mattress Company: $302,200 – $859,600 (2025 FDD · Item 7). These are each franchisor's Item 7 estimated initial investment. The low end of the disclosed estimate is lower for Amerisourcebergen Drug. At least one range spans several business formats. Estimates are not quotes, and the FDD years may differ.
    Do Amerisourcebergen Drug and Snooze Mattress Company disclose financial performance (Item 19)?
    Amerisourcebergen Drug has no reviewed Item 19 figures on file; Snooze Mattress Company has reviewed Item 19 figures for 1 location group. Different location groups are not directly comparable, and revenue is not profit.

    Answers restate the reviewed figures above. Not a ranking or recommendation.

    How Franopolis reviews FDD figures

    Keep researching